-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Li Changchun, a member of the Political Bureau of theCentral Committee, stressed during an inspection by Liuzhou Liugong Group that "independent innovation is the vitality of enterprises, and independent technology property rights are the support of brands and intangible assets." "Especially in the pharmaceutical industry, taking the road of branding and focusing on their own intellectual property rights and product innovation has become the key to the future of pharmaceutical companies to win the market." A new round ofGMPcertification, the National FoodDrug
administration's new regulations on generics, no doubt mean that some manufacturers of generic drugs still remain at a low level of repeat ingons of enterprises will gradually fade out of the marketIn the generic drugs, the homogenization of traditional medicines in the pyrethroad is particularly serious, the era of fish and pearl will no longer exist, a new round of competition has comeIndependent research and development, enterprises with intellectual property products will become the master of the new round of the market
according to the survey, in research and development and product innovation, and foreign large companies generally reached 10 to 15% of sales, China's pharmaceutical enterprises investment in research and development costs not more than 3% of sales, the general enterprise is only 0.5 to 1.0% of salesBut it is gratifying that in the implementation of theGMP, there are still some pharmaceutical enterprises in China forward-looking foresight to develop products and innovation and other software construction of the importance of The Liugong Group's subsidiary Guangxi Pure Tang Pharmaceutical Factory as early as a few years ago has been positioned to take the path of independent research and development innovationAt present, Guangxi Pure Tang Pharmaceutical Factory independently developed a number of exclusive varieties and national chinese medicine protection varieties, "in recent years, due to drinking water, natural living environment destruction, lack of scientific life conditioning, coupled
with the trend of aging of the population
; ", Guangxi Pure Tang Pharmaceutical Factory responsible person, such as told reporters, through the nationalGMP certification of investment of nearly 10 million independent research and development of exclusive products "Jade leaf fire tablets", has become the domestic fire anti-inflammatory drugs in the well-known brand, in similar products in the sales ranking, because of its reasonable group, the effectiveness of the exact results and won the trust and favor of the vast number of consumers, the treatment of acute phytosacline total efficiency of 95% And the upcoming listing of hot poison double-clearing tablets, is the enterprise to further invest heavily in independent research and development of its anti-heat detoxification effect of the country's three new drugs Its group is more scientific, more advanced technology, more significant efficacy, will be better for the vast number of patients to serve, to create better economic and social benefits with the 24th order packaging replacement, 25 pharmaceutical price reduction, 53 order of the two regulations, GMP's further integration, the State Food and Drug Administration of the new regulations on generic drugs, scientific and technological innovation as the driving force for development, strong research and development and technological innovation strength, rich new drug reserves and other forward-looking development strategies, will be implemented in the country in the second round of GMP fully show potential advantages, the new implementation can promote the Guangxi pure banand pharmaceutical factory and other innovative enterprises to gain additional market share and opportunities The pure medicinal material
sedatives with local characteristics will become a new competitive highlight of traditional Chinese medicine
the biggest factor affecting the quality of traditional Chinese medicine is the of medicinal herbs used by the pharmaceutical industry Whether the source of medicinal herbs is authentic, the effective ingredient content of medicinal herbs in the authentic production area is particularly high, whether the varieties of medicinal herbs are excellent or not, the planting and harvesting time of different regions of the same variety is also different, the use of highly toxic pesticides, fertilizers, etc in the planting process will also lead to pesticide residues, heavy metal content exceeds the standard; "For this reason, the state has specially formulated A GAP for the production of medicinal herbs, that is, the quality management norms of chinese medicinal materials production, and the production of chinese medicinal materials
the whole process of management and control Of course, the quality of traditional Chinese medicine is restricted by modern extraction, concentration, production process, dosage form, etc , but good medicinal herbs are the most basic premise of the production of good medicines, but also the most critical factor Guangxi Pure Tang Pharmaceutical Factory is located in Guangxi subtropical monsoon region, Guangxi's special natural ecological conditions, rich resources of Chinese herbal medicine make it China's "natural medicine bank", "biological resources gene bank" and "the home of Chinese herbal medicine." According to statistics, Guangxi has 4623 species of herbal medicine, accounting for about one-third of the country's medicinal plant resources, ranking second in the country In addition, Guangxi also has nearly a thousand kinds of marine biological resources and unique medical resources of zhuang, Yao and Yao ethnic minorities Guangxi is not only rich in medicinal resources, but also artificial cultivation of medicinal herbs is also quite large-scale, the existing variety of cultivation of medicinal herbs 28,000, of which has formed a large-scale production base of 12 The area of cultivation of medicinal herbs in the region has 520,000 mu, accounting for about one-fifth of the country's cultivated area, the annual acquisition volume has reached 18 million kg, is one of the country's four major medicinal production areas " Guangxi is China's natural medicine bank, especially the fire-type herbs such as 'Jade Leaf Golden Flower', 'Reverse Grass' and so on are the unique and valuable herbs of Guangxi 100,000 mountains Guangxi pure Tang pharmaceutical factory responsible person told reporters, "Guangxi pure Tang pharmaceutical factory has always been adhering to the 'pure medicinal materials, pure medicine' concept, 'Jade leaf clear fire tablets' is the use of Guangxi's unique tunnel clear fire class of expensive medicinal herbs, choose to adapt to the 'jade leaf golden flower', 'reverse grass' and other growing natural environment within the region for procurement, and constantly explore the essence of national medicine, the manufacture of pure medicine, dedication to the people."